- POSITIVE
Quarterly Revenue Inventurus Knowledge Jun-2026 Quarterly Revenue is Rs 477 Cr which is growth of 48.2% YoY.
- POSITIVE
Quarterly Net Profit Inventurus Knowledge Jun-2026 Quarterly Net Profit is Rs 163 Cr which is growth of 44.0% YoY.
NSE: IKS | BSE: 544309
Inventurus Knowledge Live Share Price Today, Share Analysis and Chart
aboutInventurus Knowledge Solutions Ltd. (IKS Health) operates as a healthcare enablement platform, primarily serving provider organizations in the United States. The company provides technology-enabled solutions designed to optimize revenue, reduce expen... Read More
1703.80-7.10(-0.41%)
87,867
NSE+BSE Volume
NSE 30 Oct, 2026 3:31 PM (IST)
Mid-range PerformerThese stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investorsView SimilarEmbed DVM
Please subscribe to view forecaster data
Inventurus Knowledge Stock Price Analysis
Day Price Range-0.4% 1 Day return | 1703.8 (LTP) 1,678.91,725.3 LowHigh |
|---|---|
Week Price Range5.3% 1 Week return | 1703.8 (LTP) 1,585.61,725.3 LowHigh |
Month Price Range-2.5% 1 Month return | 1703.8 (LTP) 1,582.51,798.3 LowHigh |
52 Week Price Range3.5% 1 Year return | 1703.8 (LTP) 1,2621,970 LowHigh |
Inventurus Knowledge Forecaster - Analyst Share Price Target and Estimates
Revenue forecast
EPS forecast
CURRENT EPS
AVG. ESTIMATE
Consensus Recommendation
9 ANALYST Recommendations
BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Forecaster
Competitors/Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Inventurus Knowledge quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 476.7 | 414.1 | 405.4 | 357.4 | 321.6 | 292.1 | 247.6 | 246.3 | 202.5 | 257.1 | ||
Operating Exp. | 255.9 | 201.2 | 207.3 | 177.8 | 169.7 | 161.4 | 138.3 | 124.3 | 122.6 | 112.9 | |
Operating Profit | 219.4 | 211.5 | 196.3 | 177.9 | 149.7 | 128.9 | 103 | 115.7 | 78.8 | 137.4 | |
Operating Profit Margin % | 46.17% | 51.25% | 48.64% | 50.01% | 46.87% | 44.41% | 42.69% | 48.21% | 39.11% | 54.90% | |
Depr. | 10.9 | 11 | 10 | 9.1 | 7.3 | 7.3 | 7 | 7.1 | 7.5 | 5.1 | |
Interest | 3.6 | 3.7 | 3.3 | 2.5 | 2.7 | 2.5 | 3.7 | 2.3 | 2.4 | 6.4 | |
Profit Before Tax | 206.4 | 198.4 | 184.9 | 168 | 141.8 | 120.8 | 98.7 | 112.5 | 69.9 | 132.7 | |
Tax | 43.8 | 29.3 | 38.6 | 29.6 | 29 | 21 | 15.9 | 20.4 | 12.7 | 19.8 | |
Net Profit | 162.6 | 169 | 146.2 | 138.4 | 112.9 | 99.8 | 82.8 | 92.1 | 57.3 | 113 | |
EPS Adj. latest | 9.5 | 9.9 | 8.5 | 8.1 | 6.6 | 5.8 | 4.8 | 5.4 | 3.3 | 6.6 | |
Net profit TTM | 616.2 | 566.5 | 497.3 | 433.9 | 387.6 | 332 | - | - | - | - | |
Basic EPS TTM | 36.1 | 33.2 | 29.2 | 25.5 | 22.8 | 19.5 | - | - | - | - | |
Earnings Transcripts | |||||||||||
AI Summary | |||||||||||
Results PDF | |||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Inventurus Knowledge Technical Analysis
Inventurus Knowledge EMA & SMA
Neutral0
4 bullish, 4 bearish
Bullish4
Bearish4
| 5 Day | 1694.4 |
|---|---|
| 10 Day | 1693.3 |
| 12 Day | 1695.9 |
| 20 Day | 1709.7 |
| 26 Day | 1719.0 |
|---|---|
| 50 Day | 1739.6 |
| 100 Day | 1732.9 |
| 200 Day | 1697.7 |
Inventurus Knowledge Delivery And Volume
Daily Avg. Delivery Volume %
30 Oct, 202665.2%
Week62.5%
Month56.1%
Inventurus Knowledge Active Candlesticks
Highwave Uptrend Long Legged Doji Uptrend Rickshaw Man Uptrend Spinning Top Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Inventurus Knowledge Resistance and Support
1702.67
Pivot
| First Resistance | 1726.4 |
|---|---|
| Second Resistance | 1749.1 |
| Third Resistance | 1772.8 |
| First Support | 1680.0 |
|---|---|
| Second Support | 1656.3 |
| Third Support | 1633.6 |
| Day RSI | 47.5 |
|---|---|
| Day MACD | -23.1 |
| Day MFI | 30.1 |
| Day MACD Signal Line | -26 |
Inventurus Knowledge Beta
| 1 Month | 0.3 |
|---|---|
| 1 Year | 0.7 |
| 3 Month | 0.3 |
|---|---|
| 3 Year | - |
Inventurus Knowledge Price Change Analysis
↓-2.5%
Over 1 Month
LowHigh
1582.51798.3
↓-7.9%
Over 3 Months
LowHigh
1582.51970
↑3.0%
Over 6 Months
LowHigh
1519.51970
↑3.5%
Over 1 Year
LowHigh
12621970
Inventurus Knowledge Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SCOTT HAYWORTH | Block | Sell | 04 Jun 2026 | 1654.90 | 200,000 | NSE |
| KEDAARA CAPITAL PUBLIC MARKETS FUND I | Block | Purchase | 04 Jun 2026 | 1654.90 | 200,000 | NSE |
| SCOTT HAYWORTH | Block | Sell | 03 Jun 2026 | 1633 | 155,000 | BSE |
| KEDAARA CAPITAL PUBLIC MARKETS IFSC FUND I | Block | Purchase | 03 Jun 2026 | 1633 | 155,000 | BSE |
| BERJIS MINOO DESAI | Block | Sell | 22 May 2026 | 1580 | 600,000 | NSE |
| 3P INDIA EQUITY FUND 1M | Block | Purchase | 22 May 2026 | 1580 | 160,000 | NSE |
| 3P INDIA EQUITY FUND 1 | Block | Purchase | 22 May 2026 | 1580 | 240,000 | NSE |
| EDELWEISS MUTUAL FUND A/C - EDELWEISS SMALL CAP FUND | Block | Purchase | 22 May 2026 | 1580 | 200,000 | NSE |
| NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | Bulk | Purchase | 19 Dec 2024 | 1899.67 | 1,750,000 | NSE |
| NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | Bulk | Purchase | 19 Dec 2024 | 1923.92 | 1,659,435 | NSE |
Inventurus Knowledge Corporate Actions
Inventurus Knowledge Board Meetings
Inventurus Knowledge past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
105 Nov 2026 | Quarterly Results | - |
205 Aug 2026 | Quarterly Results | - |
313 May 2026 | Audited Results | - |
404 Feb 2026 | Quarterly Results | - |
530 Oct 2025 | Quarterly Results | - |
Inventurus Knowledge Research Reports
Inventurus Knowledge research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 106 Sep 2026 | ICICI Direct | 2110 | 1788 | Buy | 18.01% | -4.71% | |
| 206 Aug 2026 | Aditya Birla Money Limited | 2080 | 1831.9 | Buy | 13.54% | -6.99% | |
| 305 Aug 2026 | Motilal Oswal Target | 2075 | 1763.1 | Buy | 17.69% | -3.36% | |
| 414 May 2026 | Aditya Birla Money Limited | 1960 | 1595.3 | Buy | 22.86% | 6.8% | |
| 525 Apr 2026 | Motilal Oswal | 1902 | 1438 | Buy | 32.27% | 18.48% |
Inventurus Knowledge Corporate Filings
Inventurus Knowledge BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 30 Oct 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026. | Inventurus Knowledge Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026. Further, in continuation of our earlier letter dated September 28, 2026 under subject 'Intimation of closure of Trading Window' and in terms of the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their immediate relatives and SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company by the Designated Persons of the Company and/or their immediate relatives shall remain closed from October 01, 2026 till November 07, 2026 (both days inclusive) for the purpose of said financial results. | |
| 08 Oct 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026 is enclosed. | |
| 28 Sep 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Closure of Trading Window | Intimation regarding closure of trading window for the unaudited financial results for the quarter and half year ended September 30, 2026 is enclosed. | |
| 25 Sep 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Enclosed is the Investor/Analyst Meet intimation to be held on September 30, 2026. | |
| 23 Sep 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Enclosed is the Analyst/ Institutional Investor Meet intimation. |
Inventurus Knowledge Documents
Inventurus Knowledge Earnings Call
Inventurus Knowledge earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 11 Aug 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | Link |
| 06 Aug 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | Link |
| 06 Aug 2026 | Inventurus Knowledge Solutions Results Earnings Call for Q1FY27 | AudioVideo |
| 20 May 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 14 May 2026 | Inventurus Knowledge Solutions Results Earnings Call for Q4FY26 & Full Year | AudioVideo |
Inventurus Knowledge Annual Reports
Inventurus Knowledge financials, including annual results, balance sheets, and cash flow statements.
Inventurus Knowledge Credit Ratings
Inventurus Knowledge credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
| Date | Rating Agency | Company Name | Description | Links |
|---|---|---|---|---|
| 21 Jun 2026 | care ratings | Inventurus Knowledge Solutions Limited | Link |
Inventurus Knowledge Investor Presentations
Inventurus Knowledge investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 05 Aug 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 13 May 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 24 Apr 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 23 Apr 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 23 Apr 2026 | Inventurus Knowledge Solutions Ltd - 544309 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
Inventurus Knowledge - Company Profile
Inventurus Knowledge Management Structure
Inventurus Knowledge management structure with salaries, total experience, and qualifications.
Inventurus Knowledge Board of Directors
Inventurus Knowledge Board of directors with salaries, total experience, and qualifications.
Website: www.ikshealth.com
About the company - Business Profile
Inventurus Knowledge Solutions Ltd. (IKS Health) operates as a healthcare enablement platform, primarily serving provider organizations in the United States. The company provides technology-enabled solutions designed to optimize revenue, reduce expenses, and manage administrative burdens for physician enterprises and healthcare systems. IKS Health integrates clinical and financial workflows to delegate clinical documentation and revenue cycle management tasks away from healthcare providers.
Key Points
Key Facts
- Founded Year: 2006 (as per CIN registration).
- Headquarters: Navi Mumbai, Maharashtra, India.
- Stock Listing: Listed on the National Stock Exchange (NSE: IKS) and BSE (544309).
- Key Leadership: Sachin Gupta (Founder and Global CEO), Berjis Desai (Chairman).
Operations and Resources
- Facilities: Operates from Mindspace Business Park (SEZ) in Navi Mumbai, with a key U.S. presence in Coppell, Texas.
- Workforce: As of December 31, 2025, the company employed 13,350 professionals, including 2,072 clinically trained staff and 542 technology-focused employees.
- Specialization: The company focuses on delegating chores across the patient journey, utilizing a specialized workforce to support U.S.-based healthcare organizations.
Market and Significance
- Target Market: Physician enterprises in the United States, targeting a total addressable market (TAM) of $260 billion in 2023, with an outsourced market potential of $34 billion.
- Strategic Importance: Serves 600+ healthcare organizations as of Q3 FY26.
- Client Base: Maintains long-term relationships, with the top 10 clients having an average vintage of over 5 years.
Business Model and Revenue
- Business Model: Operates a "Care Enablement Platform" that provides technology-led services for clinical, financial, and operational tasks. The model is built on high revenue predictability, with 90%+ of revenue coming from repeat customers as of December 2025.
- Revenue Breakdown (FY 2024-25 Consolidated):
- Revenue from Operations: ₹26,639.94 million, showing a growth of approximately 46.5% over the previous year (₹18,179.28 million).
- Profit After Tax: ₹4,860.59 million, compared to ₹3,704.86 million in FY 2023-24.
- Geographical Focus: While operations are centered in India, the primary revenue source is the U.S. healthcare market.
Innovation and Recent Developments
- Strategic Acquisition: In April 2026, IKS Health announced an agreement to acquire TruBridge, Inc., a move aimed at expanding its healthcare technology and services footprint.
- Technology Focus: The platform focuses on clinical documentation and revenue cycle management (RCM) through technology integration, aimed at reducing physician burnout by managing non-clinical administrative tasks.
Future Outlook
- Growth Strategy: Continues to scale its clinically trained and technology workforce to address the rising demand for outsourced healthcare services in the U.S., which is expected to grow at a CAGR of 12% (2023-2028E).
- Strategic Initiatives: Integration of the TruBridge acquisition and expansion of the care delivery pyramid by adding technology-enabled layers to physician enterprises.
References
